Contracts › 75N93023C00001
75N93023C00001: To Develop the Ppz Series of Small Molecule Pan-Filovirus Entry Inhibitors Through Lead Optimization, Selection of a Preclinical Candidate, and Ind-Enabling Preclinical Studies.
Awarded to Microbiotix, Inc. by National Institutes of Health (NIH).
$8.8Mobligated
$14.2Mpotential value
01 March 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93023C00001 |
|---|---|
| Awardee | Microbiotix, Inc. |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | MA |
| Offers received | 10 |
| Period of performance | 01 November 2022 to 01 March 2028 |
| Potential end | 01 March 2028 |
| Estimated recompete solicitation | ~Q3 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record